Results 171 to 180 of about 1,027,416 (202)
Some of the next articles are maybe not open access.
Characteristics of community-acquired carbapenem-resistant Enterobacterales
Journal of Antimicrobial Chemotherapy, 2022AbstractBackgroundCommunity-acquired carbapenem-resistant Enterobacterales (CA-CRE) are an important threat.MethodsIn CRACKLE-2, we defined patients with CA-CRE as admitted from home, without pre-existing conditions, and a positive culture within 48 h of admission.
Rima Shrestha +73 more
openaire +2 more sources
Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United States
Microbial Drug Resistance, 2022Carbapenem-resistant Enterobacterales (CRE) are a growing public health concern due to resistance to multiple antibiotics and potential to cause health care-associated infections with high mortality. Carbapenemase-producing CRE are of particular concern given that carbapenemase-encoding genes often are located on mobile genetic ...
Jesse T Jacob +2 more
exaly +3 more sources
Clinical and Genomic Characterization of Carbapenem-Resistant Enterobacterales Bloodstream Infections in Patients With Hematologic Malignancies [PDF]
BackgroundCarbapenem-resistant Enterobacterales (CRE) bloodstream infections (BSIs) pose a significant risk to patients with hematologic malignancies, yet the distinct features and outcomes of these infections are not thoroughly understood.MethodsThis ...
Zhichang Zhao, Jiangqing Huang
exaly +2 more sources
The epidemiology of carbapenem-resistant Enterobacterales in a single center in Oman
International Journal of Infection Control, 2023Background: Carbapenem-resistant Enterobacterales (CRE) are a global public health threat associated with significant morbidity and mortality. Objectives: The study aims to describe the epidemiology, microbiology and outcome of patients with CRE infection or colonization during an active surveillance program and to determine the risk factors for the ...
Ahmed AL Yarabi +5 more
openaire +1 more source
Predictors of Resistance to Ceftazidime-Avibactam in Carbapenem-Resistant Enterobacterales
Infectious Diseases in Clinical Practice, 2022Background Ceftazidime-avibactam (CAZ-AVI) is a safe and effective treatment option for carbapenem-resistant Enterobacterales (CRE). However, predictors of resistance to CAZ-AVI have not been well defined. Therefore, our study describes risk factors for resistance to CAZ-AVI in hospitalized patients with CRE infections.
Tae Eun Park +6 more
openaire +1 more source
Carbapenem-resistant Enterobacterales (CRE): The storm is coming
Intensive and Critical Care Nursing, 2023Zahar, Jean-Ralph, Blot, Stijn
openaire +4 more sources
Carbapenem-resistant Enterobacterales in the USA
The Lancet Infectious Diseases, 2020Sumanth, Gandra, Carey-Ann D, Burnham
openaire +2 more sources

